Future study on membrane PI turnover, tissue-specific T cell recognition, and TCR maturation, and avidity of Treg and naive CD8-positive TCR will elucidate hematopoietic stem cell biology and show novel therapeutic strategies in PNH. The gene discussed is CD8A; the disease is paroxysmal nocturnal hemoglobinuria.